Medipol Bahçelievler Hospital specialises in Hormonal Therapy, employing contemporary treatment methods aligned with established precision oncology protocols. Founded in 2022, the hospital has JCI accreditation and is located in Istanbul, Turkey with a capacity of 441 beds, providing services to both local and international patients.

Hormonal therapy is intended to suppress or manage the proliferation of hormone-dependent cancer cells by interfering with the hormones they utilise. The therapy depends on the type of cancer present and may involve hormone-blocking drugs or hormone-reducing therapies. To prepare for treatment, specialists review pathology, hormone receptor tests, the stage of the cancer, detailed medical history, and the patient's general health to develop a plan tailored to the patient.